Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation

Cited in blog · Lancet Diabetes & Endocrinology. · 2025

Prado CM, et al. (2025). Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation. Lancet Diabetes & Endocrinology.

Authors

Prado CM, et al.

Research lens

Prado CM, et al. (2025). Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation. Lancet Diabetes & Endocrinology.

  • blog
  • protein-intake-women-aging-2026-07-31